These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7424529)

  • 1. [A study of release from tablets. A comparison of four methods (author's transl)].
    Fu YK; Xu AX; Bao JX; Li DL; Zhang XF; Xing CY
    Yao Xue Xue Bao; 1980 Jul; 15(7):422-8. PubMed ID: 7424529
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dynamics of the drug release from tablets. Part 7: Comparison of three liberation models on Cholestil tablets (author's transl)].
    Pasich J; Niedworok E; Zajaç M
    Pharmazie; 1980 Dec; 35(12):778. PubMed ID: 7208581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An interlaboratory cooperative study about pharmaceutical solids dissolution control (author's transl)].
    Jeannin C; Romier G; Verain A
    J Pharm Belg; 1979; 34(2):83-95. PubMed ID: 512823
    [No Abstract]   [Full Text] [Related]  

  • 4. [The influence of temperature on disintegration and dissolution time of tablets with a cellulose component as a binder (author's transl)].
    Delonca H; Joachim J; Mattha A
    J Pharm Belg; 1978; 33(3):171-8. PubMed ID: 682103
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some typical methods of data treatment in the research of release from tablets (author's transl)].
    Fang JQ
    Yao Xue Xue Bao; 1980 Jul; 15(7):441-8. PubMed ID: 7424533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electron-microscopic studies on the texture of sulphathiazole and sulphathiazole tablets (author's transl)].
    Kedvessy G; Selmeczi B; Pintye-Hódi K; Kala H; Moldenhauer H; Giese R
    Pharmazie; 1982 Feb; 37(2):132-4. PubMed ID: 7071119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preferred orientation of crystalline particles within tablets. II. Effects of shape of aspirin crystals on their orientation within tablets and breaking strength of tablets (author's transl)].
    Nakai Y; Fukuoka E; Nakagawa H
    Yakugaku Zasshi; 1978 Feb; 98(2):184-90. PubMed ID: 650392
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dynamics of the drug release from tablets. Part 6: Liberation of glaucine from Tussiglauzin Dragées (author's transl)].
    Pasich J; Niedworok E; Warzecha U
    Pharmazie; 1980 Dec; 35(12):777. PubMed ID: 7208580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the pharmaceutical technology of film coating (author's transl)].
    Kala H; Dittgen M; Moldenhauer H; Zessin G
    Pharmazie; 1979 Nov; 34(11):755-65. PubMed ID: 397492
    [No Abstract]   [Full Text] [Related]  

  • 11. [The dynamics of the drug release from dragées. Part 3: Indometnacin (author's transl)].
    Wojdak H; Pasich J
    Pharmazie; 1980 Aug; 35(8):480-1. PubMed ID: 7433498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ethanol on aspirin release from hypromellose matrices.
    Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
    Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The desintegration mechanism of pharmaceutical tablets with starch (author's transl)].
    Couvreur P; Roland M
    J Pharm Belg; 1976; 31(5):511-32. PubMed ID: 993973
    [No Abstract]   [Full Text] [Related]  

  • 15. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of polymorphous transformations of sulfanilamide during table manufacture (author's transl)].
    Cruaud O; Duchêne D; Puisieux F; Chauvet A; Masse J
    J Pharm Belg; 1981; 36(1):15-20. PubMed ID: 7229900
    [No Abstract]   [Full Text] [Related]  

  • 17. [The bioavailability of tetracycline tablets manufactured by pharmaceutical factories in China (author's transl)].
    Li T; Meng JX; Liu DY; Zhu SF; Lu SZ; Gao XY; Shen LL; Yang WS
    Yao Xue Xue Bao; 1981 Nov; 16(11):842-8. PubMed ID: 7342680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
    Fukuda M; Peppas NA; McGinity JW
    Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.